![Aron Feingold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Aron Feingold formerly worked at Sangamo Therapeutics, Inc., as Head-Media & Investor Relations from 2018 to 2022 and Geron Corp., as Head-Investor & Media Relations from 2022 to 2025.
Anciens postes connus de Aron Feingold
| Sociétés | Poste | Fin |
|---|---|---|
| GERON CORPORATION | Investor Relations Contact | 01/06/2025 |
| SANGAMO THERAPEUTICS, INC. | Investor Relations Contact | 01/03/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
